According to this regulatory filing, Pappas has raised a new $85.7 million investment fund. Over the past 25 years, the Durham, NC based company has made investments in a large portfolio of life science companies. Their areas of focus include biotech, drug delivery, medical device, and related ventures in the US and Canada.
Recent investments include: Ribometrex (developing therapeutics that target RNA), Mirum Pharmaceutical (focused on cholestatic liver disease), and Milestone Pharmaceutical (focused on treatments for tachycardias). The company made six investments during September through November of 2018.
